LITS
Lite StrategyFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Composite grade F from latest DB weights. Momentum 20.5 / Value 40.6
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.0.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
20
Value
41
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -Analysis date unavailable; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-11-02 • Vendor: Data Vendor v1
Scores
As of 2026-11-04 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-11-04
Investment thesis
As of 2026-11-04
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-11-04. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $31.00
Why
Momentum20 · Δ7d -
Value41 · Δ7d +0.0
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta +0.0.
Contradictions & invalidation
- • Mixed signals. Wait for cleaner trend confirmation.
Catalyst clock
No dated catalyst is available.
Lead driver: Value · See fundamentals
Momentum
20
30% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
70% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.1
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 20.5 / Value 40.6
Fundamentals (TTM)As of 2026-11-02
Fundamentals (TTM)
As of 2026-11-02
Market Cap
$29.43M
Beta
0.32
Shares Out
30.41M
P/E (TTM) · Derived
-0.5
P/S (TTM)
-
P/FCF (TTM) · Derived
-1.57
Rev YoY
-100.0%
EPS YoY
+71.8%
Gross Margin
+98.8%
Op Margin
+22.3%
Net Debt
-$18.01M
Current Ratio
11.53
As of 2026-11-04 • Updated nightlySource: Internal modelMethods & Data